CN101485303A - Exfoliated cell preservative fluid - Google Patents
Exfoliated cell preservative fluid Download PDFInfo
- Publication number
- CN101485303A CN101485303A CNA2009100374348A CN200910037434A CN101485303A CN 101485303 A CN101485303 A CN 101485303A CN A2009100374348 A CNA2009100374348 A CN A2009100374348A CN 200910037434 A CN200910037434 A CN 200910037434A CN 101485303 A CN101485303 A CN 101485303A
- Authority
- CN
- China
- Prior art keywords
- agent
- buffer
- anticoagulant
- preservative fluid
- cell preservative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a preservation solution for exfoliated cells, which is characterized by comprising a pH buffering agent, an osmotic pressure maintaining agent, an anti-corrosion antistaling agent, a fixative for maintaining cellular morphologies, an anticoagulant, a mucus softener, proteinase K and a component for destroying red blood cells. Compared with the prior art, the preservation solution has the advantages that the cell storage rate is high, the storage time at normal temperature is long, the mucus is sufficiently dissolved and the red blood cells are partially destroyed, the sheet-making effect comprises quite even cell distribution, the cellular morphologies are good, the cytolymph and the cell nucleus are divided clearly and are well arranged, the brightness of the cytolymph and the cell nucleus is quite good, and the karyoplasms, the morphological structures and the amount of the cells are quite clear.
Description
Technical field
The present invention relates to a kind of exfoliated cell preservative fluid.
Background technology
Living cells has physiological function, biologic activity and intrinsic cellular morphology and structure, has using value aspect a lot.But, it places if being broken away from original living environment, cells physiological function, biologic activity and intrinsic cellular morphology and structure will change, conventional method is exactly that the cell that comes off is carried out freezing preservation, and freezing preservation needs special freezing equipment, relatively more expensive, and, owing to there is the harm of pair cell damage in freezing, the course of defrosting, thereby cause cytometaplasia or distortion, influence follow-up work.
Thus, the solution that cast-off cells are preserved has appearred being specifically designed to, as the preservation liquid (PresetverCyt of the new Bai Shi of the U.S. (Tinpreper TCT) production on the market
TM), this preservation liquid is and the matching used reagent of machine Tinpreper-2000, costs an arm and a leg.For reducing application cost, the researcher has developed a kind of new preservation formula of liquid, application reference number is open " exfoliated cell preservative fluid " (publication number: CN1834233A) of Chinese patent application of 200610017591.9, the preservation liquid of this application is grouped into by following one-tenth, by volume part meter: 5 parts~10 parts of 40 parts~60 parts of methyl alcohol or ethanol, phosphate buffer or 20 parts~40 parts of trishydroxymethylaminomethane hydrochloride buffers, formaldehyde or 5 parts~10 parts in acetone, EDTAP dipotassium ethylene diamine tetraacetate or disodium ethylene diamine tetraacetates.
The patent documentation of this technical field again can application reference number be open " aqueous solution for cell preservation " (publication number: CN101310009A) of Chinese patent application of 200680042980.5, this aqueous solution comprises thickener, antifreezing agent, sugar, but do not contain natural animal source component, as serum and basal medium etc.Can also application reference number be that (publication number: CN101182506A), exfoliated cell preservative fluid comprises the component of following proportioning in parts by volume: methyl alcohol 10-15 part for 200710050463.9 Chinese patent application open " cast-off cells are preserved the preparation method of fixer and cell thin smear "; Ethanol 10-15 part; Glycerine 1-2 part; Polyethylene glycol 1-2 part; Formaldehyde 10-12 part; Glacial acetic acid 0.5-1 part; Mass concentration is sodium chloride 10-20 part of 0.85-0.9%; Phosphate buffer 33-68.5 part.This preservation liquid has intrinsic effective, the characteristics that cell bonding die rate is high of cell.
Summary of the invention
Technical problem to be solved by this invention is that a kind of cell storage rate height, long exfoliated cell preservative fluid of holding time are provided at the above-mentioned state of the art.
The present invention solves the problems of the technologies described above the technical scheme that is adopted: a kind of exfoliated cell preservative fluid is characterized in that comprising that pH buffer, osmotic pressure keeps agent, antisepsis antistaling agent, is used to keep fixative, anticoagulant, mucus softening agent, the humectant of cellular morphology and destroys erythrocytic composition.
As preferably, described pH buffer pH value is 6.5~7.4.
As preferably, at least a among the PBS that described pH buffer is, Tris HCl or the PIPES;
It is sodium chloride solution that described osmotic pressure is kept agent;
Described antisepsis antistaling agent is at least a in benzoic acid sodium salt, the benzoic acid sylvite;
Described fixative is at least a in absolute ethyl alcohol, methyl alcohol, paraformaldehyde, acetone, the coumarin;
Described anticoagulant is that ethylenediamine tetra-acetic acid two is received, at least a in the EDTAP dipotassium ethylene diamine tetraacetate, heparin;
Described mucus softening agent is a Proteinase K;
Described humectant is a carbolic acid;
The erythrocytic composition of described destruction is at least a in sodium bicarbonate, the tertiary sodium phosphate.
As preferably, comprise following component and percentage by weight:
Sodium chloride 0.5%~0.9%
Sodium bicarbonate 0.1%~0.5%
Tertiary sodium phosphate 0.1%~0.5%
Anticoagulant 5%~10%
Antisepsis antistaling agent 1%
Proteinase K: 0.1~0.5%
Paraformaldehyde 1%~4%
Coumarin 1%~4%
Carbolic acid 1%~5%,
Also be added with following component and percent by volume ratio:
PH buffer 50%~70%
Absolute ethyl alcohol 12%~20%
Methyl alcohol 10%~15%
Acetone 1%~4%,
Wherein, described anticoagulant is that ethylenediamine tetra-acetic acid two is received, a kind of in the EDTAP dipotassium ethylene diamine tetraacetate, heparin, described antisepsis antistaling agent is a kind of in benzoic acid sodium salt, the benzoic acid sylvite, and described pH buffer is a kind of among PBS, Tris HCl or the PIPES.
Compared with prior art, the invention has the advantages that: preserve each component rational proportion in the liquid, collaborative mutually, make cell storage rate height, can preserve length under the normal temperature, the longlyest can reach 2 years; Can fully dissolve mucus and partial destruction red blood cell; It is very even that production effect has cell distribution, cellular morphology is intact, and endochylema and cell nucleus boundary are clear, well arranged, and the bright property of endochylema and cell nucleus is very good, the morphosis and the quantity of the very clear cell of caryoplasm can be used for HPV-DNA, Chlamydia and SABC test simultaneously; Can be provided for the special-purpose liquid base of other position cytolgical examinations; Same sample can repeat film-making repeatedly, and has homogeneity; Cell-preservation liquid is nontoxic pollution-free, guarantees operator ' s health safety; Fully kept the cell component that diagnostic significance is arranged; Deployment cost is lower, is easy to promote.
Embodiment
Embodiment describes in further detail the present invention below in conjunction with accompanying drawing.
Embodiment 1: the exfoliated cell preservative fluid in the present embodiment comprises as follows:
Components in weight percentage: 0.7% sodium chloride, 0.25% tertiary sodium phosphate, 7.5% ethylenediamine tetra-acetic acid two is received, one of in the EDTAP dipotassium ethylene diamine tetraacetate, heparin, 1% benzoic acid is received salt (or sylvite), 3% paraformaldehyde, 3% coumarin, 0.1% Proteinase K, 0.3% sodium bicarbonate, 2.5% carbolic acid.
Components in percentage by volume: 60%pH buffer (pH7), 16% absolute ethyl alcohol, 12.5% methyl alcohol, 3% acetone, wherein, the pH buffer is a kind of among PBS, Tris HCl, the PIPES.
Embodiment 2: the exfoliated cell preservative fluid in the present embodiment comprises as follows:
Components in weight percentage: 0.9% sodium chloride, 0.1% tertiary sodium phosphate, 10% ethylenediamine tetra-acetic acid two is received, one of in the EDTAP dipotassium ethylene diamine tetraacetate, heparin, 1% benzoic acid is received salt (or sylvite), 4% paraformaldehyde, 4% coumarin, 0.5% Proteinase K, 0.5% sodium bicarbonate, 1% carbolic acid.
Components in percentage by volume: 50%pH buffer (pH6.5), 20% absolute ethyl alcohol, 15% methyl alcohol, 4% acetone, wherein, the pH buffer is a kind of among PBS, Tris HCl, the PIPES.
Embodiment 3: the exfoliated cell preservative fluid in the present embodiment comprises as follows:
Components in weight percentage: 0.5% sodium chloride, 0.5% tertiary sodium phosphate, 5% ethylenediamine tetra-acetic acid two is received, one of in the EDTAP dipotassium ethylene diamine tetraacetate, heparin, 1% benzoic acid is received salt (or sylvite), 1% paraformaldehyde, 4% coumarin, 0.3% Proteinase K, 0.1% sodium bicarbonate, 5% carbolic acid.
Components in percentage by volume: 70%pH buffer (pH7.4), 12% absolute ethyl alcohol, 10% methyl alcohol, 2% acetone, wherein, the pH buffer is a kind of among PBS, Tris HCl, the PIPES.
Result of the test shows, the exfoliated cell preservative fluid cell storage rate height of embodiment 1, embodiment 2 and embodiment 3, holding time are long, can preserve under the normal temperature 2 years.
Claims (4)
1, a kind of exfoliated cell preservative fluid is characterized in that comprising that pH buffer, osmotic pressure keeps agent, antisepsis antistaling agent, is used to keep fixative, anticoagulant, mucus softening agent, the humectant of cellular morphology and destroys erythrocytic composition.
2, exfoliated cell preservative fluid according to claim 1 is characterized in that described pH buffer pH value is 6.5~7.4.
3, exfoliated cell preservative fluid according to claim 2 is characterized in that
At least a among the PBS that described pH buffer is, Tris HCl or the PIPES;
It is sodium chloride solution that described osmotic pressure is kept agent;
Described antisepsis antistaling agent is at least a in benzoic acid sodium salt, the benzoic acid sylvite;
Described fixative is at least a in absolute ethyl alcohol, methyl alcohol, paraformaldehyde, acetone, the coumarin;
Described anticoagulant is that ethylenediamine tetra-acetic acid two is received, at least a in the EDTAP dipotassium ethylene diamine tetraacetate, heparin;
Described mucus softening agent is a Proteinase K;
Described humectant is a carbolic acid;
The erythrocytic composition of described destruction is at least a in sodium bicarbonate, the tertiary sodium phosphate.
4, exfoliated cell preservative fluid according to claim 3 is characterized in that comprising following component and percentage by weight:
Sodium chloride 0.5%~0.9%
Sodium bicarbonate 0.1%~0.5%
Tertiary sodium phosphate 0.1%~0.5%
Anticoagulant 5%~10%
Antisepsis antistaling agent 1%
Proteinase K: 0.1~0.5%
Paraformaldehyde 1%~4%
Coumarin 1%~4%
Carbolic acid 1%~5%,
Also be added with following component and percent by volume ratio:
PH buffer 50%~70%
Absolute ethyl alcohol 12%~20%
Methyl alcohol 10%~15%
Acetone 1%~4%,
Wherein, described anticoagulant is that ethylenediamine tetra-acetic acid two is received, a kind of in the EDTAP dipotassium ethylene diamine tetraacetate, heparin, described antisepsis antistaling agent is a kind of in benzoic acid sodium salt, the benzoic acid sylvite, and described pH buffer is a kind of among PBS, Tris HCl or the PIPES.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2009100374348A CN101485303A (en) | 2009-02-26 | 2009-02-26 | Exfoliated cell preservative fluid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2009100374348A CN101485303A (en) | 2009-02-26 | 2009-02-26 | Exfoliated cell preservative fluid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101485303A true CN101485303A (en) | 2009-07-22 |
Family
ID=40888493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2009100374348A Pending CN101485303A (en) | 2009-02-26 | 2009-02-26 | Exfoliated cell preservative fluid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101485303A (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101999343A (en) * | 2010-10-26 | 2011-04-06 | 深圳华大基因科技有限公司 | Cell preserving fluid and preparation method and use thereof |
CN102113481A (en) * | 2010-12-24 | 2011-07-06 | 厦门迈威生物科技有限公司 | Exfoliated cell preservation solution and preparation method thereof |
CN102258003A (en) * | 2010-05-28 | 2011-11-30 | 孝感市中心医院 | Liquid based cell preserving fluid |
CN103120153A (en) * | 2012-11-26 | 2013-05-29 | 刘召宏 | Exfoliative cells preserving fluid |
CN103196729A (en) * | 2013-04-10 | 2013-07-10 | 吴鹏 | Reagent for processing mucus |
CN103461320A (en) * | 2013-08-19 | 2013-12-25 | 安徽信灵检验医学科技有限公司 | Non-isotonic preserving fluid for liquid-based thin-layer exfoliative cells |
CN104041484A (en) * | 2014-05-23 | 2014-09-17 | 科蒂亚(新乡)生物技术有限公司 | Cell preservation liquid |
CN104585162A (en) * | 2014-12-30 | 2015-05-06 | 李东 | Novel environment-friendly nontoxic liquid-based cell preservation liquid |
CN105241726A (en) * | 2015-09-14 | 2016-01-13 | 黄小军 | Immunohistochemical staining method and applications of immunohistochemical staining method in cervical tumorous lesion screening |
CN106234354A (en) * | 2016-09-30 | 2016-12-21 | 上海市奉贤区中心医院 | A kind of cervix cell preservation solution |
CN106993606A (en) * | 2017-04-20 | 2017-08-01 | 苏州新赛美生物科技有限公司 | A kind of cells frozen storing liquid without albumen and serum and preparation method thereof |
CN107509722A (en) * | 2017-08-30 | 2017-12-26 | 迈克生物股份有限公司 | Sample preservation liquid |
CN108184814A (en) * | 2017-08-24 | 2018-06-22 | 南京福怡科技发展股份有限公司 | A kind of Sample preservation liquid and preparation method and application |
CN108402033A (en) * | 2018-04-10 | 2018-08-17 | 南京福怡科技发展股份有限公司 | One kind having preprocessing function cervical exfoliated cell preservative fluid and application |
CN109517883A (en) * | 2018-12-05 | 2019-03-26 | 广州市达信智能科技有限公司 | The preservation liquid of cast-off cells in a kind of human faecal mass sample |
CN111449056A (en) * | 2020-05-25 | 2020-07-28 | 山西汉济堂医疗科技有限公司 | Novel cell preservation solution and preparation method thereof |
CN112841173A (en) * | 2021-01-25 | 2021-05-28 | 赵丽歌 | Hematopoietic stem cell cryopreservation liquid and cryopreservation method |
CN114323903A (en) * | 2021-12-28 | 2022-04-12 | 广州安必平医药科技股份有限公司 | Exfoliative cell treatment reagent, preparation method, use method and application thereof |
CN116649330A (en) * | 2023-07-17 | 2023-08-29 | 深圳市森盈智能科技有限公司 | Liquid-based exfoliated cell preservation liquid, kit and application |
CN114323903B (en) * | 2021-12-28 | 2024-05-14 | 广州安必平医药科技股份有限公司 | Treatment reagent for exfoliated cells, preparation method, use method and application thereof |
-
2009
- 2009-02-26 CN CNA2009100374348A patent/CN101485303A/en active Pending
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102258003A (en) * | 2010-05-28 | 2011-11-30 | 孝感市中心医院 | Liquid based cell preserving fluid |
CN101999343B (en) * | 2010-10-26 | 2013-11-06 | 深圳华大基因健康科技有限公司 | Cell preserving fluid and preparation method and use thereof |
CN101999343A (en) * | 2010-10-26 | 2011-04-06 | 深圳华大基因科技有限公司 | Cell preserving fluid and preparation method and use thereof |
CN102113481B (en) * | 2010-12-24 | 2013-03-13 | 厦门迈威生物科技有限公司 | Exfoliated cell preservation solution and preparation method thereof |
CN102113481A (en) * | 2010-12-24 | 2011-07-06 | 厦门迈威生物科技有限公司 | Exfoliated cell preservation solution and preparation method thereof |
CN103120153A (en) * | 2012-11-26 | 2013-05-29 | 刘召宏 | Exfoliative cells preserving fluid |
CN103196729A (en) * | 2013-04-10 | 2013-07-10 | 吴鹏 | Reagent for processing mucus |
CN103461320A (en) * | 2013-08-19 | 2013-12-25 | 安徽信灵检验医学科技有限公司 | Non-isotonic preserving fluid for liquid-based thin-layer exfoliative cells |
CN103461320B (en) * | 2013-08-19 | 2015-09-02 | 安徽信灵检验医学科技有限公司 | An a kind of conserving liquid such as not grade for liquid base thin layer cast-off cells |
CN104041484A (en) * | 2014-05-23 | 2014-09-17 | 科蒂亚(新乡)生物技术有限公司 | Cell preservation liquid |
CN104585162B (en) * | 2014-12-30 | 2017-06-16 | 李东 | A kind of nontoxic liquid based cell preservative fluid of novel environment friendly |
CN104585162A (en) * | 2014-12-30 | 2015-05-06 | 李东 | Novel environment-friendly nontoxic liquid-based cell preservation liquid |
CN105241726A (en) * | 2015-09-14 | 2016-01-13 | 黄小军 | Immunohistochemical staining method and applications of immunohistochemical staining method in cervical tumorous lesion screening |
CN106234354A (en) * | 2016-09-30 | 2016-12-21 | 上海市奉贤区中心医院 | A kind of cervix cell preservation solution |
CN106234354B (en) * | 2016-09-30 | 2019-05-21 | 上海市奉贤区中心医院 | A kind of cervix cell preservation solution |
CN106993606A (en) * | 2017-04-20 | 2017-08-01 | 苏州新赛美生物科技有限公司 | A kind of cells frozen storing liquid without albumen and serum and preparation method thereof |
CN108184814A (en) * | 2017-08-24 | 2018-06-22 | 南京福怡科技发展股份有限公司 | A kind of Sample preservation liquid and preparation method and application |
CN107509722B (en) * | 2017-08-30 | 2020-11-10 | 迈克生物股份有限公司 | Specimen preservation solution |
CN107509722A (en) * | 2017-08-30 | 2017-12-26 | 迈克生物股份有限公司 | Sample preservation liquid |
CN108402033A (en) * | 2018-04-10 | 2018-08-17 | 南京福怡科技发展股份有限公司 | One kind having preprocessing function cervical exfoliated cell preservative fluid and application |
CN109517883A (en) * | 2018-12-05 | 2019-03-26 | 广州市达信智能科技有限公司 | The preservation liquid of cast-off cells in a kind of human faecal mass sample |
CN111449056A (en) * | 2020-05-25 | 2020-07-28 | 山西汉济堂医疗科技有限公司 | Novel cell preservation solution and preparation method thereof |
CN112841173A (en) * | 2021-01-25 | 2021-05-28 | 赵丽歌 | Hematopoietic stem cell cryopreservation liquid and cryopreservation method |
CN114323903A (en) * | 2021-12-28 | 2022-04-12 | 广州安必平医药科技股份有限公司 | Exfoliative cell treatment reagent, preparation method, use method and application thereof |
CN114323903B (en) * | 2021-12-28 | 2024-05-14 | 广州安必平医药科技股份有限公司 | Treatment reagent for exfoliated cells, preparation method, use method and application thereof |
CN116649330A (en) * | 2023-07-17 | 2023-08-29 | 深圳市森盈智能科技有限公司 | Liquid-based exfoliated cell preservation liquid, kit and application |
CN116649330B (en) * | 2023-07-17 | 2024-03-01 | 深圳市森盈智能科技有限公司 | Liquid-based exfoliated cell preservation liquid, kit and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101485303A (en) | Exfoliated cell preservative fluid | |
CN101999343B (en) | Cell preserving fluid and preparation method and use thereof | |
CN101856016B (en) | Diluent for preserving porcine semen at normal temperature | |
CN103120153A (en) | Exfoliative cells preserving fluid | |
CN108041022A (en) | A kind of new plasma DNA and haemocyte preserve liquid | |
CN105394026B (en) | A kind of candidate stem cell freezes new method | |
JP2009517086A5 (en) | ||
CN101881778B (en) | Reticulocyte mimics and preparation method thereof | |
CN104041484B (en) | A kind of cell-preservation liquid | |
CN101368172A (en) | Freeze drying protective agent for rubricyte and use method in freeze drying process | |
Shands Jr et al. | Endotoxin-induced hepatic damage in BCG-infected mice | |
CN104548187A (en) | Modified alginic acid and gelatin blended sponge as well as preparing method and application thereof | |
CN109832261A (en) | A kind of cells frozen storing liquid and its application | |
CN108553481A (en) | It is a kind of that there is the carbohydrate composition for promoting wound healing effect and its application | |
CN102620950B (en) | Platelet preserving agent | |
CN111789100B (en) | Application of DMSO-free cryopreservation solution in cryopreservation of oocytes or embryos | |
US7659372B2 (en) | Menstrual fluid simulant containing blood product, gelatin, polyacrylamide and buffer | |
CN110476951B (en) | Application of heparin sodium in preparation of diluent for cryopreservation of goat sperm and preparation method of heparin sodium | |
CN100430472C (en) | Canine semen dilution liquid | |
CN107760673B (en) | Stabilizer for free DNA and blood collection tube for detecting free DNA | |
Frederiksen | Cardiopulmonary bypass in humans: bypassing unfractionated heparin | |
CN101766842B (en) | Biological tissue material for artificial organs and preparation method thereof | |
CN1232634C (en) | Diluent for sperm of blue fox | |
Yura et al. | Structural effect of galactose residue in synthetic glycoconjugates on interaction with rat hepatocytes | |
CN108124853A (en) | A kind of store method of mescenchymal stem cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 510663, Guangdong, Guangzhou, Luogang District Science City, 11 Kaiyuan Avenue, science and technology enterprise accelerator building A6, 3 floor Applicant after: Guangzhou Hongqi Optical Instrument Technology Co., Ltd. Address before: No. 80 Guangzhou science and technology innovation base in A district city moon 510663 Guangzhou Road, Guangdong Province Science Department of 612-619 Applicant before: Guangzhou Hongqi Optical Instrument Technology Co., Ltd. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20090722 |